Daniel Virnich - Nov 12, 2024 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Chief Executive Officer
Signature
/s/ Mark Hueppelsheuser, Attorney-in-Fact for Daniel Virnich
Stock symbol
TOI
Transactions as of
Nov 12, 2024
Transactions value $
$0
Form type
4
Date filed
11/18/2024, 06:50 PM
Previous filing
May 23, 2024
Next filing
Nov 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common stock Other $0 -78.1K -8.52% $0.00 839K Nov 12, 2024 Direct F1
transaction TOI Common stock Other $0 -117K -13.96% $0.00 722K Nov 12, 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the forfeiture of restricted earn-out shares that were unvested due to failure to meet earnout targets of the Issuer's stock price of $12.50 per share for 20 days within any 30 consecutive trading days for the three-year period following November 12, 2021, the date of the closing of the Business Combination, subject to continued employment at such time.
F2 Reflects the forfeiture of restricted earn-out shares that were unvested due to failure to meet earnout targets of the Issuer's stock price of $15.00 per share for 20 days within any 30 consecutive trading days for the three-year period following November 12, 2021, the date of the closing of the Business Combination, subject to continued employment at such time.